The stocks to watch out for July 4 include Lupin, Kotak Mahindra, GAIL, Steel Strips Wheels and Tech Mahindra.

USFDA has given the final approval to Zydus Cadila to market Misoprostol Tablets, 100 mcg and 200 mcg. The drug will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

GAIL (India) Ltd. successfully commissioned the 165 km Gorakhpur project under the Pradhan Mantri Urja Ganga (PMUG) national gas pipeline project.

Asian Granito India Ltd (AGIL) received a hearty response from the dealer meet organised during June 16 to July 2, 2019. The company has landed orders to the tune of Rs. 175 crore.

Dr. Reddy’s Laboratories Limited has announced the launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial, a therapeutic equivalent generic version of Hemabate injection, 250 mcg/mL, approved by the US Food and Drug Administration (USFDA).

Kotak Mutual Fund, has launched Kotak Focused Equity Fund, an open-ended equity scheme. Read on to find if you should subscribe

Emotions are something which drives human behaviour and in turn their decisions. Let’s find out which emotions may disrupt your personal finances.

The USFDA has successfully completed the inspection of JB Chemicals & Pharmaceuticals Limited's (JBCPL) newly set up and commissioned solid oral dosage formulation manufacturing facility at Panoli, Gujarat.

Following stocks are close to their 52-weeks low as at 1:08 p.m. on July 03, 2019.

Kalpataru Power Transmission Limited (KPTL) has entered into binding agreements with CLP India Private Limited to sell its stake in 3 power transmission assets for an estimated enterprise value of Rs. 3,275 crore.